RSS

fast track designation

The US Food and Drug Administration (FDA) has granted fast track designation to Infirst Healthcare’s haemoglobin spray, Granulox, for the treatment of diabetic foot ulcers (DFUs). Read more

News

Biotech company, Shire, has been granted fast track designation by the US Food and Drug Administration (FDA) for SHP607, which is indicated for the prevention of chronic lung disease in extremely premature infants. Read more

News

Drug discovery and development company, AiCuris, has been granted fast track designation by the US FDA for oral pritelivir — its lead candidate for the treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised adults. Read more

News